Anil Kapoor

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Gary R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 3.6K citations

Medicine, Oncology, Chemotherapy +10

Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline

Jennifer T. Anger, Una Lee, Roger Chou et al. · The Journal of Urology · 2019 · 468 citations

Medicine, Infectious Diseases, Urology +16

A phase 3, randomized, 3-arm study of temsirolimus (TEMSR) or interferon-alpha (IFN) or the combination of TEMSR + IFN in the treatment of first-line, poor-risk patients with advanced renal cell carcinoma (adv RCC)

G. R. Hudes, Michael A. Carducci, Piotr Tomczak et al. · Journal of Clinical Oncology · 2006 · 210 citations

Medicine, Oncology, Pharmacology +9

Guidelines for the diagnosis and management of recurrent urinary tract infection in women

Shawn Dason, Jeyapandy T. Dason, Anil Kapoor · Canadian Urological Association Journal · 2011 · 201 citations · Full text

Medicine, Infectious Diseases, Urology +12